NERV FY 2018 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$53M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$17,467

Operating Income

-$52M

Net Income

-$50M

EPS (Diluted)

$-10.35

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$42M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$139M

Total Liabilities

$49M

Stockholders' Equity

$90M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$17,467	-$11,094	-57.4%
Operating Income	-$52M	-$41M	-25.6%
Net Income	-$50M	-$32M	-59.2%